Phosphate Buffered Saline (PBS) diluent

OTHER7 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Avian InfluenzaInfluenzaInfluenza Immunisation

Phase 1

H5N1 Mix and Match With MF59

CompletedNCT01317745

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2011-05-31End: 2012-09-30Updated: 2013-01-25

H5N1 Mix and Match With AS03

CompletedNCT01317758

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2011-05-31End: 2012-09-30Updated: 2013-01-18

Phase 2

Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly

CompletedNCT03312231

National Institute of Allergy and Infectious Diseases (NIAID)Avian Influenza, Influenza Immunisation

Start: 2018-02-14End: 2019-09-26Updated: 2024-09-19

Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4

CompletedNCT03318315

National Institute of Allergy and Infectious Diseases (NIAID)Avian Influenza, Influenza, Influenza Immunisation

Start: 2018-02-20End: 2019-07-25Updated: 2020-08-06

2013/2017 H7N9 Prime-Boost Interval

CompletedNCT03589807

National Institute of Allergy and Infectious Diseases (NIAID)Avian Influenza, Influenza Immunisation

Start: 2018-08-21End: 2020-06-14Updated: 2021-08-02

Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza

CompletedNCT03682120

National Institute of Allergy and Infectious Diseases (NIAID)Avian Influenza, Influenza Immunisation

Start: 2018-11-02End: 2020-04-30Updated: 2021-05-17

2017 A/H7N9 IIV Revaccination

CompletedNCT03738241

National Institute of Allergy and Infectious Diseases (NIAID)Avian Influenza, Influenza Immunisation

Start: 2018-12-18End: 2020-06-19Updated: 2021-07-30

Related Papers

Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens.

2025-01-042 citations

Immunogenicity and Safety of AS03‐Adjuvanted H7N9 Influenza Vaccine in Adults (18–64 and ≥65 Years): A Phase 1/2, Randomized, Placebo‐Controlled Trial

Influenza and Other Respiratory Viruses2024-12-01

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults

Clinical Infectious Diseases2024-03-278 citations

Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial

The Journal of Infectious Diseases2023-07-197 citations

The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination

npj Vaccines2022-08-3020 citations

Safety and immunogenicity of monovalent H7N9 influenza vaccine with AS03 adjuvant given sequentially or simultaneously with a seasonal influenza vaccine: A randomized clinical trial.

2022-04-227 citations

A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults

Vaccines2020-06-107 citations

Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant

Open Forum Infectious Diseases2014-01-0131 citations